BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1281 related articles for article (PubMed ID: 26832880)

  • 21. Does omentectomy in epithelial ovarian cancer affect survival? An analysis of the Surveillance, Epidemiology, and End Results database.
    McNally L; Teng NN; Kapp DS; Karam A
    Int J Gynecol Cancer; 2015 May; 25(4):607-15. PubMed ID: 25756404
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Positron emission tomography/computed tomography predictors of overall survival in stage IIIC/IV ovarian cancer.
    Risum S; Loft A; Engelholm SA; Høgdall E; Berthelsen AK; Nedergaard L; Lundvall L; Høgdall C
    Int J Gynecol Cancer; 2012 Sep; 22(7):1163-9. PubMed ID: 22810969
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multiple Cycles of Neoadjuvant Chemotherapy Associated With Poor Survival in Bulky Stage IIIC and IV Ovarian Cancer.
    Ren Y; Shi T; Jiang R; Yin S; Wang P; Zang R
    Int J Gynecol Cancer; 2015 Oct; 25(8):1398-404. PubMed ID: 26222486
    [TBL] [Abstract][Full Text] [Related]  

  • 24. FIGO stage IIIC endometrial carcinoma: resection of macroscopic nodal disease and other determinants of survival.
    Bristow RE; Zahurak ML; Alexander CJ; Zellars RC; Montz FJ
    Int J Gynecol Cancer; 2003; 13(5):664-72. PubMed ID: 14675352
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lymph-vascular space invasion and number of positive para-aortic node groups predict survival in node-positive patients with endometrial cancer.
    Watari H; Todo Y; Takeda M; Ebina Y; Yamamoto R; Sakuragi N
    Gynecol Oncol; 2005 Mar; 96(3):651-7. PubMed ID: 15721407
    [TBL] [Abstract][Full Text] [Related]  

  • 26. FIGO stage IIIC endometrial carcinoma with metastases confined to pelvic lymph nodes: analysis of treatment outcomes, prognostic variables, and failure patterns following adjuvant radiation therapy.
    Nelson G; Randall M; Sutton G; Moore D; Hurteau J; Look K
    Gynecol Oncol; 1999 Nov; 75(2):211-4. PubMed ID: 10525373
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The incidence of pelvic and para-aortic lymph node metastasis in uterine papillary serous and clear cell carcinoma according to the SEER registry.
    Mattes MD; Lee JC; Metzger DJ; Ashamalla H; Katsoulakis E
    J Gynecol Oncol; 2015 Jan; 26(1):19-24. PubMed ID: 25310855
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lymphatic spread among women with primary peritoneal carcinoma.
    Eltabbakh GH; Mount SL
    J Surg Oncol; 2002 Nov; 81(3):126-31. PubMed ID: 12407724
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lymph node involvement in epithelial ovarian cancer: sites and risk factors in a series of 355 patients.
    Fournier M; Stoeckle E; Guyon F; Brouste V; Thomas L; MacGrogan G; Floquet A
    Int J Gynecol Cancer; 2009 Nov; 19(8):1307-13. PubMed ID: 20009882
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Implementation of Extensive Cytoreduction Resulted in Improved Survival Outcomes for Patients with Newly Diagnosed Advanced-Stage Ovarian, Tubal, and Peritoneal Cancers.
    Raspagliesi F; Bogani G; Ditto A; Martinelli F; Chiappa V; Borghi C; Scaffa C; Morano F; Maltese G; Lorusso D
    Ann Surg Oncol; 2017 Oct; 24(11):3396-3405. PubMed ID: 28795373
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Survival Rates between Early Stage Endometrial Carcinoma With or Without Para-Aortic Lymph Node Resection.
    Thanagumtorn K
    J Med Assoc Thai; 2016 Sep; 99(9):975-81. PubMed ID: 29927197
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term survival in patients with para-aortic lymph node metastasis with systematic retroperitoneal lymphadenectomy followed by adjuvant chemotherapy in endometrial carcinoma.
    Hiura M; Nogawa T; Matsumoto T; Yokoyama T; Shiroyama Y; Wroblewski J
    Int J Gynecol Cancer; 2010 Aug; 20(6):1000-5. PubMed ID: 20683408
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The new FIGO staging system for ovarian, fallopian tube, and primary peritoneal cancer.
    Zeppernick F; Meinhold-Heerlein I
    Arch Gynecol Obstet; 2014 Nov; 290(5):839-42. PubMed ID: 25082067
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Should pelvic and para-aortic lymphadenectomy be different depending on histological subtype in epithelial ovarian cancer?
    Roger N; Zafrani Y; Uzan C; Gouy S; Rey A; Pautier P; Lhommé C; Duvillard P; Castaigne D; Morice P
    Ann Surg Oncol; 2008 Jan; 15(1):333-8. PubMed ID: 17943386
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Liver resection for ovarian cancer liver metastases as part of cytoreductive surgery is safe and may bring survival benefit.
    Bacalbasa N; Dima S; Brasoveanu V; David L; Balescu I; Purnichescu-Purtan R; Popescu I
    World J Surg Oncol; 2015 Aug; 13():235. PubMed ID: 26243426
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognosis for endometrial cancer patients treated with systematic pelvic and para-aortic lymphadenectomy followed by platinum-based chemotherapy.
    Sueoka K; Umayahara K; Abe A; Usami T; Yamamoto A; Nomura H; Matoda M; Okamoto S; Omatsu K; Kondo E; Kato K; Takeshima N
    Int J Gynecol Cancer; 2015 Jan; 25(1):81-6. PubMed ID: 25347094
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Results of optimal debulking surgery with bowel resection in patients with advanced ovarian cancer.
    Derlatka P; Sienko J; Grabowska-Derlatka L; Palczewski P; Danska-Bidzinska A; Bidzinski M; Czajkowski K
    World J Surg Oncol; 2016 Feb; 14():58. PubMed ID: 26923029
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pooled analysis of the prognostic relevance of disseminated tumor cells in the bone marrow of patients with ovarian cancer.
    Fehm T; Banys M; Rack B; Janni W; Marth C; Blassl C; Hartkopf A; Trope C; Kimmig R; Krawczyk N; Wallwiener D; Wimberger P; Kasimir-Bauer S
    Int J Gynecol Cancer; 2013 Jun; 23(5):839-45. PubMed ID: 23694981
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic factors and clinical outcome of patients with recurrent early-stage epithelial ovarian cancer: an Italian multicenter retrospective study.
    Gadducci A; Cosio S; Zola P; Sostegni B; Fuso L; Sartori E
    Int J Gynecol Cancer; 2013 Mar; 23(3):461-8. PubMed ID: 23370604
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Outcome of Epithelial Ovarian Cancer: Time for Strategy Trials to Resolve the Problem of Optimal Timing of Surgery.
    Van de Putte G; Oben J; Prenen L; Schobbens JC; Vlasselaer J; Van Holsbeke C; Debrock G; Van Eycken P; de Jonge E
    Int J Gynecol Cancer; 2015 Jul; 25(6):993-9. PubMed ID: 25914962
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 65.